Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients (Q33649923)

28 July 2017

title

Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients (English)

1 reference

28 July 2017

0 references

1 reference

7

Chester V Oddis

1 reference

28 July 2017

1

Rohit Aggarwal

1 reference

28 July 2017

Elaine Cassidy

2

1 reference

28 July 2017

Noreen Fertig

3

1 reference

28 July 2017

Diane Carol Koontz

4

1 reference

28 July 2017

Mary Lucas

5

1 reference

28 July 2017

Dana P Ascherman

6

1 reference

28 July 2017

language of work or name

English

0 references

publication date

19 February 2013

1 reference

Annals of the Rheumatic Diseases

28 July 2017

published in

1 reference

28 July 2017

volume

73

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

227-232

1 reference

Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4031026

Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4031026

Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4031026

Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4031026

Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4031026

Clinical implications of autoantibody screening in patients with autoimmune myositis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4031026

Polymyositis-dermatomyositis-associated interstitial lung disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4031026

Update on myositis-specific and myositis-associated autoantibodies

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4031026

Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4031026

Autoantibody to U3 Nucleolar Ribonucleoprotein (Fibrillarin) In Patients with Systemic Sclerosis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4031026

A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4031026

Polymyositis and dermatomyositis (first of two parts)

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4031026

Polymyositis and dermatomyositis (second of two parts)

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4031026

Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases

14 July 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201800

Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201800

Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201800

Survival, mortality and causes of death in inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201800

Anti-U3 RNP autoantibodies in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201800

Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality

21 January 2018

1 reference

12 December 2020

Interstitial lung disease in polymyositis and dermatomyositis

1 reference

12 December 2020

Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease

1 reference

12 December 2020

Autoantibodies to aminoacyl-tRNA synthetases

1 reference

12 December 2020

Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies

1 reference

12 December 2020

Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis

1 reference

12 December 2020

Predicting factors of interstitial lung disease in dermatomyositis and polymyositis

1 reference

12 December 2020

Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies

1 reference

12 December 2020

Severe pulmonary hypertension in Anti-Jo-1 syndrome

1 reference

12 December 2020

Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis

1 reference

12 December 2020

A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement

1 reference

12 December 2020

10.1136/ANNRHEUMDIS-2012-201800

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference